| Literature DB >> 35936465 |
Osama Usman1, Muhammad Ikram2, Namra Abid3, Mohsin Saeed4, Aneeqa Bashir4, Walid Nabgan5, Nosheen Mushahid1, Mujtaba Ikram6.
Abstract
Metal-based antimicrobials have the potential to profile sustainable solutions to infection care and health. In this study, we report the synthesis of rGO-ZnO hybrid nanostructures by a simple co-precipitation approach with various mass ratios of GO, and their antimicrobial potential was assessed. The structural analysis confirms the presence of a hexagonal wurtzite structure with peak shifting in hybrid nanostructures and increases in crystallite size (11-24 nm). Raman spectra revealed GO doping in the D band (1350 cm-1) and G band (1590 cm-1). Field emission scanning electron microscopy (FESEM) and transmission electron microscopy (TEM) were performed to investigate the surface morphologies of the synthesized sediments, which showed a change in the morphology of ZnO from non-uniform spherical nanoparticles to a rod-like morphology of the prepared hybrid nanostructures. RAMAN spectra revealed that the retained functional groups on rGO planes were significant in anchoring ZnO to rGO. At lowest and maximum doses of ZnO, substantial bactericidal zones (p < 0.05) for S. aureus (1.55 and 1.95 mm) and E. coli (1.25 and 1.70 mm) were achieved accordingly. Additionally, the inhibition regions were 2.45-3.85 mm and 3.75-6.85 mm for S. aureus whereas (2.05-3.25 mm) and (2.95-3.90 mm) for E. coli at the lowest and maximum concentrations.Entities:
Year: 2022 PMID: 35936465 PMCID: PMC9352235 DOI: 10.1021/acsomega.2c03049
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1(a) XRD, (b) FTIR, (c) Raman spectra, and (d) zoom-in of Raman spectra of ZnO and rGO–ZnO hybrids.
Figure 2DSC/TGA curves of (a) S-1 and (b) S-2 in nitrogen.
Figure 3SEM of ZnO (a) and rGO–ZnO hybrids (S-1, S-2, S-3, and S-4) (b–e), respectively.
Figure 4TEM of (a) ZnO and (b–d) S-2, S-3, and S-4, respectively.
Microbicidal Action of rGO–ZnO Hybrid Nanostructures
| sample | 500 μg/50 μL | 1000 μg/50 μL | 500 μg/50 μL | 1000 μg/50 μL |
|---|---|---|---|---|
| ZnO | 1.55 | 1.95 | 1.25 | 1.70 |
| S-1 | 2.45 | 3.75 | 2.05 | 2.95 |
| S-2 | 2.90 | 4.60 | 2.75 | 3.10 |
| S-3 | 3.35 | 5.35 | 3.25 | 3.55 |
| S-4 | 3.85 | 6.85 | 3.65 | 3.90 |
| ciprofloxacin | 9.45 | 9.45 | 4.25 | 4.25 |
| DIW | 0 | 0 | 0 | 0 |
Inhibition regions of doped nanostructures for S. aureus.
Hybrid nanostructures areas of inhibition (mm) against E. coli.
Antimicrobial Activity of rGO–ZnO Hybrid Nanostructure Literature Comparison with the Current Work
| materials | synthesis route | bacterial strains | testing method | concentration | remarks | reference |
|---|---|---|---|---|---|---|
| rGO–ZnO | green | well diffusion | 10, 20 and 30 μg/mL | > for G +ve | ( | |
| rGO–ZnO | one-pot | disc diffusion | 50 mg/mL | effective | ( | |
| rGO–ZnO | green | broth dilution | 2.5 mg | > for G −ve | ( | |
| rGO–ZnO | hydrothermal | well diffusion | 20, 30 and 50 μL | > for G +ve | ( | |
| rGO–ZnO | co-precipitation | well diffusion | 0.5 and 1.0 mg/50 μL | > for G +ve | present study |